Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases

Abroad (travel likely)RecruitingPHASE2

Conditions

TNBC · Brain Metastasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (BIYUN WANG professor) · 8621 6417 5590

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

HS-10502 Combination Treatment in Patients With Advanced Solid Tumors

Recurrent Ovarian Cancer · HER2-negative · Advanced Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

TNBC · TNBC - Triple-Negative Breast Cancer · Early Stage Triple-Negative Breast Carcinoma

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Los Angeles, United States

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Advanced Solid Tumor · Advanced Malignant Neoplasm · Metastatic Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Irvine, United States · La Jolla, United States

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

HER2-negative Breast Cancer · Metastatic Breast Cancer · Metaplastic Breast Carcinoma

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States · Houston, United States